These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 14209761)
21. STUDIES ON THE ADMINISTRATION OF STREPTOKINASE. A METHOD TO OBTAIN THROMBOLYTIC EFFECT WITHOUT EXCESSIVE FIBRINOGENOLYSIS. HELLE I; AAS K; GODAL HC Sangre (Barc); 1964; 38():167-74. PubMed ID: 14217607 [No Abstract] [Full Text] [Related]
22. EFFECTS OF FIBRINOLYTIC AGENTS AND HEPARIN ON INTRAVASCULAR CLOT LYSIS. LEWIS JH; KERBER CW; WILSON JH Am J Physiol; 1964 Nov; 207():1044-8. PubMed ID: 14237447 [No Abstract] [Full Text] [Related]
23. ENHANCING BLOOD FIBRINOLYTIC ACTIVITY BY A NIACIN COMPOUND. II. ACTIVATION AND NONACTIVATION. AMERY A; VERMYLEN J; DEVREKER RA; VERMYLEN C Am J Med Sci; 1965 Jan; 249():66-71. PubMed ID: 14254831 [No Abstract] [Full Text] [Related]
24. [THERAPY OF THROMBOEMBOLISM AND FIBRINOLYSIS]. SANTOSTORIBIO F Prog Ter Clin; 1963 Oct; 17():9-18. PubMed ID: 14097889 [No Abstract] [Full Text] [Related]
25. FIBRINOLYTIC AND ESTEROLYTIC ACTIVITY OF HUMAN PLASMA. ADAMIS DM; MANIATIS GM Thromb Diath Haemorrh; 1965 Jun; 13():484-91. PubMed ID: 14347870 [No Abstract] [Full Text] [Related]
26. STUDIES ON THE RELATIONSHIP BETWEEN FIBRIN-STABILIZING FACTOR, CALCIUM AND INHIBITION OF FIBRINOLYSIS. TYLER HM; LACK CH Clin Sci; 1965 Jun; 28():527-36. PubMed ID: 14316258 [No Abstract] [Full Text] [Related]
27. THROMBOANGIITIS OBLITERANS: WITH SPECIAL REFERENCE TO COAGULATION AND CLOT LYSIS. ENDE N Vasc Dis; 1964 Mar; 1():83-8. PubMed ID: 14186546 [No Abstract] [Full Text] [Related]
28. [Research on fibrinolysis: the fibrinolysis factors in Kline's plasminogen]. GIACOMAZZI G Haematol Lat; 1961; 4():339-70. PubMed ID: 13898267 [No Abstract] [Full Text] [Related]
29. FIBRINOLYTIC THERAPY OF THROMBOPHLEBITIS. TWENTY-FIVE CASES STUDIED WITH SERIAL VENOGRAMS. HECKER SP Calif Med; 1964 Jul; 101(1):23-9. PubMed ID: 14179527 [TBL] [Abstract][Full Text] [Related]
30. THE PREVENTION OF ARTERIAL THROMBOSIS BY FIBRINOLYTIC ACTIVATION WITH UROKINASE: AN EXPERIMENTAL STUDY. BRADY MP; O'CONNELL L; FITZGERALD PA Ir J Med Sci; 1965 Jun; 474():261-71. PubMed ID: 14326625 [No Abstract] [Full Text] [Related]
31. [THROMBOLYSIS IN ANIMAL EXPERIMENTS: STUDIES WITH A POLYSACCHARIDE SULFO-ESTER AND WITH STREPTOKINASE]. SANDRITTER W; SCHLUETER G; KOEPPEL G Med Welt; 1964 Dec; 51():2732-9. PubMed ID: 14347382 [No Abstract] [Full Text] [Related]
32. THE EFFECT OF STREPTOKINASE ON THE PLATELET AGGREGATES IN ARTIFICIAL IN VITRO THROMBOSIS. ROZENBERG MC Aust J Exp Biol Med Sci; 1965 Jun; 43():245-54. PubMed ID: 14327521 [No Abstract] [Full Text] [Related]
33. [CLINICAL ASPECT OF FIBRINOLYSIS]. BARTA I Orv Hetil; 1963 Aug; 104():1590-3. PubMed ID: 14052314 [No Abstract] [Full Text] [Related]
34. EVALUATION OF THE FIBRINOLYTIC STATE AFTER ADMINISTRATION OF UROKINASE. BAUMGARTEN W; PRIESTER LI; HERCZEG SA; WATSON LS Proc Soc Exp Biol Med; 1964 Apr; 115():1120-4. PubMed ID: 14166574 [No Abstract] [Full Text] [Related]
35. EFFECTS OF FIBRINOLYTIC AGENTS ON EXPERIMENTAL AND CLINICAL THROMBOSIS. TSAPOGAS MJ J Clin Pathol; 1964 May; 17(3):360-1. PubMed ID: 14159483 [No Abstract] [Full Text] [Related]
36. THE EFFECT OF INDUCED FIBRINOLYSIS AND VARIOUS SUBSTANCES ON THE MAST CELLS IN THE PERITONEAL FLUID AND MESENTERY OF THE RAT. CRONBERG S; NILSSON IM Acta Pathol Microbiol Scand; 1964; 60():156-63. PubMed ID: 14121975 [No Abstract] [Full Text] [Related]
37. THE FIBRINOLYTIC SYSTEM IN HEALTH AND DISEASE. JOHNSON AJ; NEWMAN J Semin Hematol; 1964 Oct; 1():401-31. PubMed ID: 14225683 [No Abstract] [Full Text] [Related]